July 7 (Reuters) – Italy’s Stevanato Group S.p.A., a maker of glass vials for COVID-19 vaccine and other healthcare products, said on Wednesday it is seeking a valuation of over $7 billion in its initial public offering in the United States.
Reporting by Niket Nishant in Bengaluru; Editing by Bernard Orr
